Clinical Trials in Houston

Showing 15561-15580 of 17,885 trials

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

NCT01281592

This is an open-label, phase 1 study to determine the maximum tolerated dose (MTD) or appropriate target dose if MTD not reached to identify the recommended phase 2 dose of LOR-253 HCl in patients with advanced or metastatic solid tumours.

Advanced or Metastatic Solid Tumours

Aptose Biosciences Inc.36 participantsStarted Jan 2011

New York, New York, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

NCT00580112

The purpose of this study is to evaluate the effectiveness and safety of trabectedin in 3 subpopulations of participants with previously treated progressive metastatic ( spread of a cancer from one organ or part to another non-adjacent organ or part) breast cancer (abnormal tissue that grows and spreads in the body until it kills) participants.

Breast Neoplasms

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.127 participantsStarted Jun 2007

Sedona, Arizona, United States • Denver, Colorado, United States • Torrington, Connecticut, United States +30 more locations

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer

Find Trials by Condition in Houston

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches

Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

Transforming Research and Clinical Knowledge in TBI Pilot

H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers

Gene Transfer for Cancer Pain

DPBRN Longitudinal Study of Questionable Occlusal Caries Lesions

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms